Literature DB >> 21626528

Hepatic triglyceride content in individuals with reduced intestinal cholesterol absorption due to variants in Nieman Pick C1-like 1.

Ruben Ramirez1, Jonathan C Cohen, Helen H Hobbs, Jeffrey D Browning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21626528      PMCID： PMC3492950          DOI： 10.1002/hep.24461

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).

Authors:  Margarita Garcia-Calvo; JeanMarie Lisnock; Herbert G Bull; Brian E Hawes; Duane A Burnett; Matthew P Braun; James H Crona; Harry R Davis; Dennis C Dean; Patricia A Detmers; Michael P Graziano; Meredith Hughes; D Euan Macintyre; Anthony Ogawa; Kim A O'neill; Sai Prasad N Iyer; Diane E Shevell; Marsha M Smith; Yui S Tang; Amanda M Makarewicz; Feroze Ujjainwalla; Scott W Altmann; Kevin T Chapman; Nancy A Thornberry
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

3.  Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

Authors:  Hyohun Park; Toshihide Shima; Kanji Yamaguchi; Hironori Mitsuyoshi; Masahito Minami; Kohichiroh Yasui; Yoshito Itoh; Toshikazu Yoshikawa; Michiaki Fukui; Goji Hasegawa; Naoto Nakamura; Mitsuhiro Ohta; Hiroshi Obayashi; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2010-07-24       Impact factor: 7.527

4.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

5.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.

Authors:  Jonathan C Cohen; Alexander Pertsemlidis; Saleemah Fahmi; Sophie Esmail; Gloria L Vega; Scott M Grundy; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

6.  Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis.

Authors:  Lin Jia; Yinyan Ma; Shunxing Rong; Jenna L Betters; Ping Xie; Soonkyu Chung; Nanping Wang; Weiqing Tang; Liqing Yu
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

7.  Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study.

Authors:  Masato Yoneda; Koji Fujita; Yuichi Nozaki; Hiroki Endo; Hirokazu Takahashi; Kunihiro Hosono; Kaori Suzuki; Hironori Mawatari; Hiroyuki Kirikoshi; Masahiko Inamori; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Kensuke Kubota; Shiro Maeyama; Atsushi Nakajima
Journal:  Hepatol Res       Date:  2010-04-14       Impact factor: 4.288

8.  Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.

Authors:  Dick C Chan; Gerald F Watts; Seng Khee Gan; Esther M M Ooi; P Hugh R Barrett
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

Review 9.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Authors:  Raj Vuppalanchi; Naga Chalasani
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes.

Authors:  Saleemah Fahmi; Chendong Yang; Sophie Esmail; Helen H Hobbs; Jonathan C Cohen
Journal:  Hum Mol Genet       Date:  2008-04-15       Impact factor: 6.150
  10 in total
  1 in total

1.  Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.

Authors:  E C Verna; J Patel; R Bettencourt; P Nguyen; C Hernandez; M A Valasek; T Kisselva; D A Brenner; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-06-29       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.